Biotie Therapies

Biotie Therapies

Develops drugs focused on products for psychiatric disorders.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round

$363m

Valuation: $363m

Acquisition
Total Funding000k
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Biotie Therapies

Edit
Synosia Therapeutics
ACQUISITION by Biotie Therapies Jan 2011
Neurelis
ACQUISITION by Biotie Therapies Jun 2013